Page results
-
Liz O’Hara was appointed as joint chief people officer across UCLH and Whittington Health in March 2024, having held the role of director of workforce at UCLH since March 2020.
-
Professor Charles Swanton is one of three innovative cancer investigators to be awarded the prestigious Paul Marks Prize for Cancer Research by the Memorial Sloan Kettering Cancer Center (MSK).
-
Chyrel Brown became a non-executive director at UCLH in May 2022 and was appointed as vice-chair in January 2025.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
How COVID-19 impacts on the cardiovascular conditions
-
Des Haughton: Dr Russell Portrait Commission A portrait of Dr James Samuel Risien Russell, one of Britain’s first Black British consultants, was unveiled at the National Hospital for…
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
Sarcoma treatment is often extensive and can impact on a person’s ability to continue in work or return to work. While some people can continue working throughout their cancer treatment, others…
-
A UCLH patient has received an innovative treatment for radiotherapy-induced dry mouth, an irreversible serious adverse effect of head and neck cancer radiotherapy that causes permanent impairment of talking and eating.
-
We encourage our staff to live healthy lifestyles and as part of this UCLH has signed up with Vivup for our cycle to work scheme. This scheme allows staff to lease/loan bikes, cycling…
